Pancreatic β-cell neogenesis by direct conversion from mature α-cells

Stem Cells
Cheng-Ho ChungFred Levine

Abstract

Because type 1 and type 2 diabetes are characterized by loss of β-cells, β-cell regeneration has garnered great interest as an approach to diabetes therapy. Here, we developed a new model of β-cell regeneration, combining pancreatic duct ligation (PDL) with elimination of pre-existing β-cells with alloxan. In this model, in which virtually all β-cells observed are neogenic, large numbers of β-cells were generated within 2 weeks. Strikingly, the neogenic β-cells arose primarily from α-cells. α-cell proliferation was prominent following PDL plus alloxan, providing a large pool of precursors, but we found that β-cells could form from α-cells by direct conversion with or without intervening cell division. Thus, classical asymmetric division was not a required feature of the process of α- to β-cell conversion. Intermediate cells coexpressing α-cell- and β-cell-specific markers appeared within the first week following PDL plus alloxan, declining gradually in number by 2 weeks as β-cells with a mature phenotype, as defined by lack of glucagon and expression of MafA, became predominant. In summary, these data revealed a novel function of α-cells as β-cell progenitors. The high efficiency and rapidity of this process make it attractive ...Continue Reading

References

Aug 27, 2005·Diabetes·Monica TetaJake A Kushner
Apr 4, 2006·Developmental Biology·Wataru NishimuraArun Sharma
May 17, 2008·Biochemical Society Transactions·Claire BonalPedro L Herrera
Aug 30, 2008·Nature·Qiao ZhouDouglas A Melton
Dec 5, 2008·Proceedings of the National Academy of Sciences of the United States of America·Akari InadaSusan Bonner-Weir
Apr 10, 2009·Cell Metabolism·Dan KawamoriRohit N Kulkarni
Oct 13, 2009·Diabetes, Obesity & Metabolism·C DemetercoF Levine
Jan 21, 2010·Cell Metabolism·Jake A KushnerSusan Bonner-Weir
Jan 29, 2010·Nature·Thomas VierbuchenMarius Wernig

❮ Previous
Next ❯

Citations

Feb 9, 2012·Histochemistry and Cell Biology·Konstantin BlochPnina Vardi
Oct 25, 2012·In Vitro Cellular & Developmental Biology. Animal·Julie A RhodesFarzad Esni
Jul 27, 2012·Current Diabetes Reports·Yong Zhao
May 23, 2012·International Journal of Endocrinology·Xiaojie WangGarth L Warnock
Apr 27, 2013·The Journal of Clinical Investigation·Xiangwei XiaoGeorge K Gittes
Feb 26, 2013·The Journal of Clinical Investigation·Larry G Moss
Nov 10, 2010·The Review of Diabetic Studies : RDS·Isabelle Houbracken, Luc Bouwens
Nov 10, 2010·The Review of Diabetic Studies : RDS·Cheng-Ho Chung, Fred Levine
May 10, 2011·Biomedical Research·Korefumi NakamuraSusumu Seino
Oct 11, 2012·Diabetes Management·Michael J KaradimosArun Sharma
Jan 18, 2013·ISRN Endocrinology·Ahmed Mansouri
Aug 25, 2012·Journal of Transplantation·Jose Manuel Mellado-GilBenoit R Gauthier
Oct 19, 2011·Journal of Transplantation·Françoise CarlottiEelco J de Koning
Dec 29, 2010·Seminars in Immunopathology·Roberto Gianani
Sep 6, 2013·Médecine sciences : M/S·Bertrand Duvillié
Jan 27, 2016·Trends in Endocrinology and Metabolism : TEM·Rui Wei, Tianpei Hong
Jan 30, 2016·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Fernando BurdíoEnrique Berjano
Jul 15, 2015·Expert Opinion on Biological Therapy·Bernat SoriaAbdelkrim Hmadcha
Nov 30, 2010·Expert Opinion on Biological Therapy·Yujie WenSuzanne T Ildstad
May 24, 2013·Archives of Physiology and Biochemistry·Federica Tortosa, Francesco Dotta
Jan 7, 2016·Proceedings of the National Academy of Sciences of the United States of America·Mingfeng ZhangDefu Zeng
Dec 19, 2013·Translational Research : the Journal of Laboratory and Clinical Medicine·Robert J NicholsJustin P Annes
Mar 16, 2016·Molecular Metabolism·Amanda M AckermannKlaus H Kaestner
Feb 6, 2013·Diabetes Research and Clinical Practice·Nouha Ben-OthmanPatrick Collombat
Dec 25, 2012·Trends in Endocrinology and Metabolism : TEM·Joel F Habener, Violeta Stanojevic
Dec 24, 2015·Best Practice & Research. Clinical Endocrinology & Metabolism·Violeta Stanojevic, Joel F Habener
Mar 21, 2012·Journal of Diabetes·Eva TuduríTimothy J Kieffer
Mar 30, 2012·Birth Defects Research. Part C, Embryo Today : Reviews·Joëlle A BaddourPanagiotis A Tsonis
Sep 18, 2013·Diabetes, Obesity & Metabolism·L DingC Mathieu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.